Generic Name: myeloperoxidase (MPO) Quantification Kit (ELISA)
[Medical Device Manufacturing Enterprise License No.】 Beijing Drug Administration firearms production Xu 20,040,085 No.
[Medical Device Registration Certificate No.] Beijing Food and Drug Administration Apparatus (Approved) No. 2014 2400412
▲ Product name
Generic Name: myeloperoxidase (MPO) Quantification Kit (ELISA)
[Medical Device Manufacturing Enterprise License No.】 Beijing Drug Administration firearms production Xu 20,040,085 No.
[Medical Device Registration Certificate No.] Beijing Food and Drug Administration Apparatus (Approved) No. 2014 2400412
▲ Packing
96 / box 48 servings / box
▲ storage conditions and period
Storage conditions 2 ~ 8 ℃, preventing freezing, valid for 12 months.
After opening the package, please kit as soon as possible one-time run, each reagent components can not be reused.
▲ intended use
The kit for the quantitative detection of human plasma myeloperoxidase (MPO) concentration for the diagnosis of coronary heart disease, and only for in vitro testing.
▲ Applicable models
This kit needs to be detected using a microplate reader, microplate reader detection wavelength of 450nm.
▲ Products
Myeloperoxidase (MPO) are neutrophils, macrophages, monocytes and certain organizations protease secreted heme-containing heme group is one of the super family of heme peroxidase . MPO synthetic myeloid before entering the loop synthesized and stored in the azurophilic granules in the bone marrow, external stimuli can lead to neutrophil aggregation, release of myeloperoxidase (MPO).
MPO involved in all stages of atherosclerotic plaque development, from endothelial cell injury, plaque formation, progression to plaque rupture, causing a variety of complications. MPO as a predictor and prognostic indicator for patients with acute coronary syndrome, healthy people can predict future risk of cardiovascular disease, it is a systemic inflammation and oxidative stress markers, it is involved in the pathophysiology underlying coronary heart disease, For the diagnosis and prognosis of coronary heart disease have a good assessment of value in use. It can be used for clinical diagnosis of coronary heart disease.
The company's production of "myeloperoxidase (MPO) Quantification Kit" based on enzyme-linked immunosorbent assay, good reagent stability, specificity, high sensitivity, easy to operate. The product is CFDA registered products.
Copyright©2017 Beijing Unionluck Biotechnology Co., Ltd. all rights reserved. JING icp No.16053627号-1